Summary
Overview
Work History
Education
Skills
Timeline
Generic

Nehaa Nagpaul

Union City

Summary

Experienced and enthusiastic professional specializing in forecasting and market research to drive strategic planning in the pharmaceutical industry. Proven track record of using data-driven insights to support commercialization process of late-stage hematologic drugs and to inform multi-billion dollar business development decisions. Skilled in leading teams to deliver high-quality, impactful work aligned with business goals.

Overview

5
5
years of professional experience

Work History

Senior Manager, Commercialization Analytics

Bristol Myers Squibb
02.2024 - Current

Consultant

PharmaACE
11.2022 - Current
  • Working with Bristol Myers Squibb's Business Development Analytics team on forecasting various BD opportunities in the Cardiovascular, Fibrosis, Immunology and Neuroscience areas.
  • Providing key insights and recommendations to senior leadership on multi-billion dollar investment decisions.
  • Collaborating with client stakeholders to evaluate BD deals in due diligence phase, producing forecasts and investment valuations in high pressure environments.
  • Specializing in analog analysis to supplement overall strategy and to pressure test forecast feasibility.
  • Conducted market analysis and developed revenue forecasts for the $14B acquisition of Karuna by BMS in 2023
  • Awarded Certificate of Excellence in Project and Client Services in May 2023.

Senior Business Analyst

PharmaACE
07.2021 - 11.2022
  • Worked with Bristol Myers Squibb's Worldwide Hematology Business Insights and Analytics team on forecasting and strategic planning for Multiple Myeloma (MM).
  • Led and managed onshore and offshore teams' time effectively to ensure deliverables completed with high quality under tight deadlines.
  • Provided analytics-backed recommendations to supplement Long Term Financial Plans, Budget Guidance and Governance phase decision-making.
  • Collaborated with client Commercial, Access & Pricing, and Finance teams to solidify late-stage assets' clinical development plans.
  • Developed robust revenue and volume forecasts for 3 MM pipeline products (biologics and small molecules) to support commercial and clinical investment strategies.
  • Worked with market-focused teams on Revlimid, Pomalyst and Empliciti to align short term sales performance with long term projections.
  • Awarded two Certificates of Excellence in Project and Client Services in Aug 2021 and March 2022.

Biopharma Business Analyst

PharmaACE
05.2020 - 07.2021
  • Developed forecasting models for Bristol Myers Squibb's Worldwide Hematology Business Insights and Analytics Multiple Myeloma team.
  • Designed and built complex Excel models of highly fragmented market with collaborative team.
  • Models simulate elaborate patient flow, eligibility, and sequencing throughout lines of therapy to forecast financials for pipeline assets for major markets.
  • Presented models to client teams regularly and implemented feedback to optimize for client requirements.
  • Broader team utilizes models to project different clinical development scenarios, patient & competitor dynamics, and offer data-driven, strategic recommendations.

Education

Bachelor of Science (BS) - Chemical Engineering

Northwestern University
Evanston, IL
03.2020

Skills

  • Knowledgeable about drug commercialization process
  • Organized and efficient in project management
  • Effective storyboarding and communication skills
  • Expertise in designing and overseeing primary market research projects
  • Proactive and collaborative market research vendor management
  • Ability to model complex disease market dynamics in Microsoft Excel

Timeline

Senior Manager, Commercialization Analytics

Bristol Myers Squibb
02.2024 - Current

Consultant

PharmaACE
11.2022 - Current

Senior Business Analyst

PharmaACE
07.2021 - 11.2022

Biopharma Business Analyst

PharmaACE
05.2020 - 07.2021

Bachelor of Science (BS) - Chemical Engineering

Northwestern University
Nehaa Nagpaul